By Jeff Overley ( November 3, 2016, 3:49 PM EDT) -- A video from specialty drugmaker Supernus Pharmaceuticals Inc. wrongly implied that its anti-seizure medicine Oxtellar XR is approved for epilepsy and downplayed the risks of life-threatening side effects, according to a U.S. Food and Drug Administration letter released on Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.